ブレーキング
ESロシア、日本との紛争中、千島列島付近でミサイル実験を実施US米国の金融市場は債券利回りへの懸念から下落を経験TRイランのペゼシキアン大統領からの戦争と和解のメッセージITジフテリアの疑いで4歳で死亡、母親が医師を襲撃TRイスラエル、レバノン南部を標的に暴力攻撃RUフィンランド外務省、領空侵犯疑惑でロシア大使を召喚TR米国、カタールへの45億ドルのKC-46A航空機売却を承認TRラプセキの農地で大火災ESオルガ・カサド: 闘牛に革命を起こそうとする若き闘牛士CN日本の48歳の父親が富士山に登り、7歳の息子を置き去りにして一人で待機し、社会的衝撃を与えたESロシア、日本との紛争中、千島列島付近でミサイル実験を実施US米国の金融市場は債券利回りへの懸念から下落を経験TRイランのペゼシキアン大統領からの戦争と和解のメッセージITジフテリアの疑いで4歳で死亡、母親が医師を襲撃TRイスラエル、レバノン南部を標的に暴力攻撃RUフィンランド外務省、領空侵犯疑惑でロシア大使を召喚TR米国、カタールへの45億ドルのKC-46A航空機売却を承認TRラプセキの農地で大火災ESオルガ・カサド: 闘牛に革命を起こそうとする若き闘牛士CN日本の48歳の父親が富士山に登り、7歳の息子を置き去りにして一人で待機し、社会的衝撃を与えた

cholesterol

安定した20 ストーリー9 ソース最終更新日: 7/13/2026

最新のストーリー

Obese Adults Have Similar Cholesterol and Blood Pressure to Healthy Weight Individuals, Study Finds
開発中
健康·7/2/2026AIの概要

Obese Adults Have Similar Cholesterol and Blood Pressure to Healthy Weight Individuals, Study Finds

A study published in The Lancet reveals that many obese adults, particularly those over 40, now have cholesterol and blood pressure levels comparable to healthy-weight individuals, largely due to the widespread use of statins and blood pressure medications. Researchers examined data from nearly 1 million adults across several countries, finding that these risk factors have converged, though obesity still poses risks for younger adults and other health conditions.

G
Guardian UK
4 min read
Being Young And Fit No Longer Protects You From High Cholesterol: Doctor Shares Prevention Tips
開発中
健康·4/28/2026AIの概要

Being Young And Fit No Longer Protects You From High Cholesterol: Doctor Shares Prevention Tips

Abnormal cholesterol is emerging as a silent epidemic among young Indians, with 25-30% of urban youth and 15-20% of rural youth already having elevated levels. Nearly one in five at-risk individuals remain undiagnosed. A 2026 study shows nearly two in five Indian adolescents have dyslipidemia, with low HDL being the most prevalent abnormality. Dr R Govindarajan advises baseline lipid screening between ages 20-25, daily movement, and fiber-rich nutrition as prevention strategies.

T
Times of India
4 min read
Pharma Bets Big on Lp(a) Cholesterol Drugs With $5.6B Market Potential
開発中
健康·4/27/2026AIの概要

Pharma Bets Big on Lp(a) Cholesterol Drugs With $5.6B Market Potential

Novartis, Amgen and Eli Lilly are in late-stage trials for drugs targeting Lp(a), a dangerous form of cholesterol affecting one in five people worldwide. Novartis expects Phase 3 results mid-2026 for pelacarsen, with Amgen and Lilly following in 2027 and 2029. The drugs have shown 80%+ Lp(a) reduction but must now prove clinical benefit. If successful, the market could reach $5.6B by 2032, though less than 1% of U.S. adults currently get tested for Lp(a).

C
CNBC
4 min read